Facilitated By

San Antonio Medical Foundation

News

  • Amgen: 3Q Earnings Snapshot

    The world's largest biotech drugmaker posted revenue of $5.74 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks ...

  • New Research Study Points to Potential of Oleandrin as Therapeutic Strategy for Treatment of ...

    Phoenix Biotechnology, Inc., a San Antonio, Texas-based biotechnology company, was incorporated in Texas in 2003 to develop promising agents ...

  • Caprion Biosciences Leads Pre-Conference Workshop on Best Practices for Biomarkers Validation ...

    ... role in a Pre-Conference Workshop at the upcoming AAPS PharmaSci 360 conference, San Antonio, Texas. ... About Caprion Biosciences Inc.

  • Progenity Presents Data at ACG 2019 Highlighting Opportunities for Technologies Aimed at ...

    Progenity, Inc., a privately held biotechnology company, presented three ... of Gastroenterology Annual Scientific Meeting in San Antonio, Texas.

  • SA cancer research group aligns with global biotech

    The new alliance will shine a brighter spotlight on San Antonio's work in cancer research and drug development.